TA
XENE icon

TLS Advisors’s Xenon Pharmaceuticals XENE Stock Holding History

TLS Advisors’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.8M Buy
30,956
+12,098
+64% +$557K 4.27% 8
2025
Q4 		$307K Sell
18,858
-14,098
-43% -$592K 0.81% 13
2025
Q3 		$1.38M Hold
32,956
– – 4.02% 7
2025
Q2 		$1.03M Hold
32,956
– – 3.22% 7
2025
Q1 		$1.11M Hold
32,956
– – 2.5% 10
2024
Q4 		$1.29M Hold
32,956
– – 2.95% 8
2024
Q3 		$1.3M Hold
32,956
– – 2.74% 8
2024
Q2 		$1.28M Hold
32,956
– – 3.22% 8
2024
Q1 		$1.42M Hold
32,956
– – 3.3% 10
2023
Q4 		$1.52M Hold
32,956
– – 5.04% 9
2023
Q3 		$1.13M Sell
32,956
-800
-2% -$29.9K 4.56% 8
2023
Q2 		$1.3M Hold
33,756
– – 5.58% 6
2023
Q1 		$1.21M Hold
33,756
– – 6.21% 7
2022
Q4 		$1.33M Buy
+33,756
New +$1.23M 6.56% 7

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return